Tetramethylenedisulfotetramine neurotoxicity: What have we learned in the past 70 years?

被引:9
|
作者
Laukova, Marcela [1 ,5 ,7 ]
Veliskova, Jana [2 ,3 ,4 ]
Velisek, Libor [2 ,4 ,5 ]
Shakarjian, Michael P. [1 ,2 ,6 ]
机构
[1] New York Med Coll, Sch Hlth Sci & Practice, Div Environm Hlth Sci, Dept Publ Hlth, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA
[2] New York Med Coll, Dept Cell Biol & Anat, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA
[3] New York Med Coll, Dept Obstet & Gynecol, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA
[4] New York Med Coll, Dept Neurol, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA
[5] New York Med Coll, Dept Pediat, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA
[6] Rutgers Robert Wood Johnson Med Sch, Div Pulm & Crit Care Med, Dept Med, 675 Hoes Ln W, Piscataway, NJ 08854 USA
[7] Slovak Acad Sci, Biomed Res Ctr, Inst Expt Endocrinol, Dubravska Cesta 9, Bratislava 84505, Slovakia
基金
美国国家卫生研究院;
关键词
Tetramethylenedisulfotetramine; Neurotoxicology; Seizures; Vulnerable populations; Countermeasures; Pharmacotherapy; Terrorism; GAMMA-AMINOBUTYRIC-ACID; TONIC-CLONIC SEIZURES; GABA(A) RECEPTOR; STATUS EPILEPTICUS; CULTURED NEURONS; TETRAMINE; TETRAMETHYLENEDISULPHOTETRAMINE; ANTAGONISTS; PICROTOXIN; INHIBITION;
D O I
10.1016/j.nbd.2019.104491
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tetramethylenedisulfotetramine (tetramine, TETS, TMDT) is a seizure-producing neurotoxic chemical formed by the condensation of sulfamide and formaldehyde. Serendipitously discovered through an occupational exposure in 1949, it was promoted as a rodenticide but later banned worldwide due to its danger to human health. However, exceptional activity of the agent against rodent pests resulted in its clandestine manufacture with large numbers of inadvertent, intentional, and mass poisonings, which continue to this day. Facile synthesis, extreme potency, persistence, lack of odor, color, and taste identify it as an effective food adulterant and potential chemical agent of terror. No known antidote or targeted treatment is currently available. In this review we examine the origins of tetramethylenedisulfotetramine, from its identification as a neurotoxicant 70 years ago, through early research, to the most recent findings including the risk it poses in the post-911 world. Included is the information known regarding its in vitro pharmacology as a GABA(A) receptor channel antagonist, the toxic syndrome it produces in vivo, and its effect upon vulnerable populations. We also summarize the available information about potential therapeutic countermeasures and treatment strategies as well as the contribution of clinical development of TMDT poisoning to our understanding of epileptogenesis. Finally we identify gaps in our knowledge and suggest potentially fruitful directions for continued research on this dangerous, yet intriguing compound.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] ECT after 70 years: What have we learned?
    Fink, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S88 - S88
  • [2] 70 years of crystalline urease: What have we learned?
    Karplus, PA
    BIOCHEMISTRY, 1996, 35 (28) : 104 - 104
  • [3] 70 years of crystalline urease: What have we learned?
    Karplus, PA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 104 - BIOL
  • [4] 70 years of crystalline urease: What have we learned?
    Karplus, PA
    Pearson, MA
    Hausinger, RP
    ACCOUNTS OF CHEMICAL RESEARCH, 1997, 30 (08) : 330 - 337
  • [5] What Lessons Have We Learned in the Past 40 Years?
    Dyken, Mark L.
    STROKE, 2010, 41 (06) : 1073 - 1075
  • [6] Fibrates: What have we learned in the past 40 years?
    Backes, James M.
    Gibson, Cheryl A.
    Ruisinger, Janelle E.
    Moriarty, Patrick M.
    PHARMACOTHERAPY, 2007, 27 (03): : 412 - 424
  • [7] Enzyme immobilization: what have we learned in the past five years?
    Almeida, Francisco L. C.
    Prata, Ana S.
    Forte, Marcus B. S.
    BIOFUELS BIOPRODUCTS & BIOREFINING-BIOFPR, 2022, 16 (02): : 587 - 608
  • [8] Water injectivity - What we have learned in the past 30 years
    Guan, L
    Du, Y
    Wang, Z
    Xu, W
    JOURNAL OF CANADIAN PETROLEUM TECHNOLOGY, 2006, 45 (05): : 9 - 13
  • [9] Bone bioelectricity: What have we learned in the past 160 years?
    Isaacson, Brad M.
    Bloebaum, Roy D.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2010, 95A (04) : 1270 - 1279
  • [10] Cutaneous vasculitis -: What have we learned in the past 20 years?
    Callen, JP
    ARCHIVES OF DERMATOLOGY, 1998, 134 (03) : 355 - 357